 | • レポートコード：MRC2203A588 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、世界のアブレーションデバイス市場規模が予測期間中に年平均10.4％成長すると予測しています。本調査資料では、アブレーションデバイスの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、デバイス技術別（高周波、レーザー/光アブレーション、超音波、冷凍アブレーション、その他）分析、用途別（癌治療、心血管疾患治療、眼科治療、婦人科治療、泌尿器科治療）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のアブレーションデバイス市場規模：デバイス技術別（高周波、レーザー/光アブレーション、超音波、冷凍アブレーション、その他） ・世界のアブレーションデバイス市場規模：用途別（癌治療、心血管疾患治療、眼科治療、婦人科治療、泌尿器科治療） ・世界のアブレーションデバイス市場規模：エンドユーザー別（病院、外来手術センター、その他） ・世界のアブレーションデバイス市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Abbott Laboratories、AngioDynamics, Inc.、AtriCure, Inc.、Boston Scientific Corporation、BTG plc、Conmed Corporation、Johnson and Johnson、Medtronic PLC、Olympus Corporation、Smith & Nephew PLC） ・市場機会・将来の傾向 |
The global ablation devices market is expected to witness a CAGR of 10.4% during the forecast period. Certain factors that are driving the market growth include the rise in the prevalence of chronic diseases, technological advancements, and advantages associated with the device and procedure.
Ablation devices are minimally invasive and provide an alternative to the conventional surgical treatment of liver, kidney, prostate, and lung cancers, and the usage is growing rapidly owing to the increasing popularity of minimally invasive treatments as well as the rising incidence of various chronic diseases. Several companies are currently offering innovations in ablation technologies, which supports clinical efficacy, patient safety and procedural efficiency.
Key Market Trends
Cancer Treatment is Expected to Hold Significant Market Share in the Application Segment
Cancer has a major impact on societies across the world. The incidence of cancer has increased, worldwide, at a high rate in the recent decade. According to a 2018 report by the World Health Organization (WHO), the global cancer burden was estimated to have risen to 18.1 million new cases and 9.6 million deaths worldwide in 2018. One in five men and one in six women, worldwide, develop cancer during their lifetime, and one in eight men and one in eleven women die from the disease. The total number of people who are alive within five years of a cancer diagnosis is estimated to be 43.8 million. The increasing cancer burden was also attributed to several factors, including changing prevalence of certain causes of cancer linked to social and economic development. This is particularly true in rapidly growing economies, where a shift is observed from cancers related to poverty and infections to cancers associated with lifestyles more typical of industrialized countries. Hence, owing to the rising incidence of cancer, the demand for devices and technologies that treat cancer effectively and safely is bound to increase. This factor is expected to help the Ablation Devices market grow in the forecast period.
North America Dominates the Market over the Forecast Period
The investments, by many key players in this market, have grown significantly in the region, specifically in the United States. In addition, the focus on the development of products with innovative features and greater effectiveness has increased in recent times. As a result, there has been a growth in R&D funding.
The market growth in the region is also supported by the rising prevalence of cancer. Moreover, the number of people with higher risk for variety of cancers (aging population) is increasing in the region.
Competitive Landscape
The global ablation device market is moderately competitive and consists of a few major players. Companies like Abbott, AngioDynamics, Inc., AtriCure, Inc., Boston Scientific Corporation, BTG plc, Conmed Corporation, Johnson and Johnson, Medtronic PLC, Olympus Corporation, Smith & Nephew PLC, among others, hold the substantial market share in the Ablation Devices market.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Prevalence of Chronic Diseases
4.2.2 Technological Advancements
4.2.3 Emergence of Next-generation Ablation Products and Technology
4.3 Market Restraints
4.3.1 High Cost of Device
4.3.2 Lack of Awareness and Stringent Regulations
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Device Technology
5.1.1 Radiofrequency Devices
5.1.2 Laser/Light Ablation
5.1.3 Ultrasound Devices
5.1.4 Cryoablation Devices
5.1.5 Other Devices
5.2 By Application
5.2.1 Cancer Treatment
5.2.2 Cardiovascular Disease Treatment
5.2.3 Ophthalmologic Treatment
5.2.4 Gynecological Treatment
5.2.5 Urological Treatment
5.2.6 Cosmetic Surgery
5.2.7 Others
5.3 By End-Users
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 AngioDynamics, Inc.
6.1.3 AtriCure, Inc.
6.1.4 Boston Scientific Corporation
6.1.5 BTG plc
6.1.6 Conmed Corporation
6.1.7 Johnson and Johnson
6.1.8 Medtronic PLC
6.1.9 Olympus Corporation
6.1.10 Smith & Nephew PLC
7 MARKET OPPORTUNITIES AND FUTURE TRENDS